Summer/Fall 2024 | The Mark Foundation for Cancer Research

Updates from the Mark Foundation for Cancer Research

It’s been a busy and productive few months for The Mark Foundation for Cancer Research and our grantees. We’re excited to share updates on our impact, introduce a new funding opportunity, and provide more insights into our ongoing initiatives. Read on!

The Mark Foundation for Cancer Research | Our Impact

“The Mark Foundation is different from other organizations. All types of cancer are in scope for us, and that was by design, from the beginning.” -Ryan Schoenfeld, PhD, CEO of The Mark Foundation for Cancer Research

Watch our new video to learn how The Mark Foundation is accelerating progress in the fight against cancer.

2023 Annual Report

We’re excited to share our 2023 Annual Report. In it, you’ll find grantee stories, a full list of the awards we presented last year, and insights into our strategy.

Open RFP: Drug Discovery Award

We are now accepting Project Concept Letters for the Drug Discovery Award program, which offers investigators up to $1 million to discover and progress a new therapeutic agent into preclinical development. Grantees also benefit from the expertise and guidance of seasoned biopharma R&D scientists.

Project Concept Letter submissions close November 11, 2024. View the RFP for eligibility requirements and submission guidelines.

To learn more about the program and the application process, register now for a webinar with Mark Foundation CEO Ryan Schoenfeld, PhD, on October 10 at 10 a.m. EDT.

Learn More

Identifying Cancer’s Grand Challenges

We’re pleased to support Cancer Grand Challenges as they convene members of the global research community across a series of “think tanks” to identify the next round of challenge topics. The Mark Foundation will host the US think tank in NYC on October 9, with the new challenges announced in March 2025.

Co-founded in 2020 by Cancer Research UK and the National Cancer Institute, Cancer Grand Challenges aims to accelerate high-impact research and translate discoveries for public and patient benefit through global team science. We co-fund the initiative’s SPECIFICANCER, NexTGen, and MATCHMAKERS teams.
Learn more about the challenge-setting process.

Recent Grantee Publications

Our grantees continue to make important strides toward improved cancer diagnostics and therapeutics. In the third quarter of 2024, our awardees’ publications included 12 papers in top scientific journals, showcasing impactful studies that span the research spectrum from bench to bedside. Catching up on their work? View second quarter publications here.

Support Our Work

Did you know October 10 is Donor Advised Fund (DAF) Day? Too often, DAF funds go unused — but with our new online DAF portal, contributing to The Mark Foundation only takes a few clicks.

Whether you support The Mark Foundation via your DAF or a traditional one-time or recurring donation, 100% of your tax-deductible contribution is directed toward supporting world class research that will accelerate innovations from the bench to the bedside.

Help spread the word about The Mark Foundation!
Please share this email with others in your network and follow us on social media.

Donate

Follow Us